CD44 and breast cancer: These data suggest that the CD44+/CD24-/lo CSC population might undergo more symmetric self-renewing divisions as compared to the bulk population within basal-like subtypes, and that asymmetric segregation of template DNA is breast cancer subtype-dependent.